AXMOX-LP

COMPOSITION:- Moxifloxacin HCL0.5% w/v + Loteprednol Etabonate 0.5% w/v + SOC 0.005%
PACKAGE:- 5ml

AXMOX-LP by Devaksh Lifesciences utilizes “soft-steroid” technology. Loteprednol Etabonate provides potent anti-inflammatory effects but is engineered to be rapidly metabolized, significantly lowering the risk of increasing intraocular pressure. Combined with the wide spectrum action of Moxifloxacin, this combination offers a safer long-term character of treating inflammatory bacterial disease.

Key Features:

• Soft-steroid technology of a better safety profile.
• Less effects on the intraocular pressure (IOP) in comparison to Dexa.
• Strong protection of broad-spectrum antibiotics.
• Perfect with delicate patients who need controlling of inflammation.

Benefits & Advantages:

• Minimizes inflammation with no common side-effects of steroids.
• Quickened recovery of post-operative redness and swelling.
• Very successful in steroid-reactive inflammatory diseases.
• Safe when used in the medium term subject to stringent medical attention.

Usage & Clinical Highlights:

• Patient-centred towards Post-Operative Inflammation.
• Its use is recommended in Giant Papillary Conjunctivitis (GPC).
• Good in treatment of blepharitis that has secondary infection.
• Clinically preferred when the patient has a high risk of Glaucoma.
• Presents a moderate method of the healing of the ocular surface.